Our third BRAINtranslate feature for 2018 provided an insight into the experiences of the Clinical Outcomes Research (CORe) Unit researchers who represented the Melbourne Brain Centre at Royal Melbourne Hospital at last year's ECTRIMS Congress. Held in Berlin, Germany, ECTRIMS is the largest annual conference dedicated to the understanding and treatment of multiple sclerosis.
CORe UNIT AT ECTRIMS 2018 - CONFERENCE OVERVIEW
By Associate Professor Tomas Kalincik
In this video, A/Prof Tomas Kalincik (Neurologist and Research Group Leader) talks about the Clinical Outcomes Research Unit's involvement at the ECTRIMS Congress 2018 and shares his conference highlights.
ECTRIMS 2018 - PREDICTING AGGRESSIVE MULTIPLE SCLEROSIS
By Dr Charles Malpas
In the video, Dr Charles Malpas (CORe Unit) talks about his experience at ECTRIMS Congress 2018, where he presented his research on improving how we predict people at risk of developing aggressive multiple sclerosis.
ECTRIMS 2018 - PREDICTIVE FACTORS IN NMOSD
By Dr Izanne Roos
What factors can predict relapses and clinical progression in neuromyelitis optica spectrum disorders? Dr Izanne Roos (CORe Unit) discusses this research, which she presented at the 2018 ECTRIMS Congress, as well as her highlights from the recent meeting in Berlin.
ECTRIMS 2018 - INSIGHTS INTO SECONDARY PROGRESSIVE MS
By Dr Nathaniel Lizak
What do we know about disease progression in people with secondary progressive multiple sclerosis? Dr Nathaniel Lizak (CORe Unit) discusses his study in this area, presented at ECTRIMS Congress 2018, which has found that disease modifying therapies can still be effective in this stage of the disease.